Free Trial
→ INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (From Traders Agency) (Ad) Free MGRX Stock Alerts

Mangoceuticals (MGRX) News Today

Mangoceuticals logo
$1.66 +0.08 (+5.06%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.59 -0.07 (-4.22%)
As of 07/18/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

MGRX Latest News

Mangoceuticals President Tony Isaac Resigns
July 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-president-tony-isaac-resigns?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Strengthens Position with Equity Transactions
June 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-strengthens-position-with-equity-transactions?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders
May 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/mangoceuticals-files-to-sell-4-46m-shares-of-common-stock-by-selling-shareholders/ar-AA1FNZSi
Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
May 29, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-05/65513404-mangoceuticals-inc-mangoceuticals-patented-mgx-0024-delivers-100-respiratory-survival-in-poultry-studies-signaling-strong-potential-defense-again-399.htm
Mangoceuticals, Inc. Reports 100% Survival Rates in Field Studies of MGX-0024 for Poultry Respiratory Diseases
May 29, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/mangoceuticals-inc-reports-100-survival-rates-field-studies-mgx-0024-poultry-respiratory
Mangoceuticals shares results from field studies on MGX-0024
May 29, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/mangoceuticals-shares-results-field-studies-131543846.html
Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
May 27, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/27/3088671/0/en/mangoceuticals-patented-mgx-0024-delivers-100-respiratory-survival-in-poultry-studies-signaling-strong-potential-defense-against-spread-of-avian-flu.html
Mangoceuticals, Inc. Terminates Agreements with Key Partners
May 23, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-inc-terminates-agreements-with-key-partners?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Enters Wellness Pouch Market, Appoints Tim Corkum To Lead New Unit
April 27, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/mangoceuticals-enters-wellness-pouch-market-appoints-tim-corkum-lead-new-unit
Mangoceuticals enters into agreement to acquire assets of Smokeless Technology
April 27, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-enters-into-agreement-to-acquire-assets-of-smokeless-technology-1034628335
Mangoceuticals Acquires IP to Expand Product Line
April 25, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-acquires-ip-to-expand-product-line?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
April 25, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/25/3068314/0/en/mangoceuticals-announces-strategic-entry-into-high-growth-pouch-industry-through-acquisition-of-smokeless-technology-ip-and-appointment-of-tim-corkum-ex-philip-morris-executive-to-.html
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions
April 24, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/mangoceuticals-reengineering-self-care-blueprint-120000766.html
Mangoceuticals Issues Bonus Shares to Leadership
April 11, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-issues-bonus-shares-to-leadership?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Issues Common Stock in Exchange for Preferred
March 30, 2025  |  investing.comhttps://www.investing.com/news/sec-filings/mangoceuticals-issues-common-stock-in-exchange-for-preferred-93CH-3955467
Mangoceuticals Announces Equity and Leadership Changes
March 21, 2025  |  uk.investing.comhttps://uk.investing.com/news/sec-filings/mangoceuticals-announces-equity-and-leadership-changes-93CH-3986758
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting
March 19, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-inc-approves-key-amendments-at-special-meeting?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals launches PeachesRx women’s telehealth brand
February 21, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-launches-peachesrx-women-s-telehealth-brand-1034385677
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
February 20, 2025  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/mangoceuticals-announces-launch-peachesrx-womens-120000818.html
Mangoceuticals Advances Research on Respiratory Illness Prevention Technologies Targeting Avian Influenza
February 14, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/mangoceuticals-advances-research-respiratory-illness-prevention-technologies-targeting
Mangoceuticals advances research on patented respiratory illness technology
February 12, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-advances-research-on-patented-respiratory-illness-technology-1034348447
Mangoceuticals targets avian flu with water-based solution
February 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/mangoceuticals-targets-avian-flu-with-water-based-solution/ar-AA1yU9FK
Mangoceuticals Expands COO Role and Increases Compensation
February 7, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-expands-coo-role-and-increases-compensation?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals advances H1N1 study conducted by Vipragen
February 6, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-advances-h1n1-study-conducted-by-vipragen-1034322141
Mangoceuticals advances in H1N1 and H5N1 studies
February 6, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/mangoceuticals-advances-in-h1n1-and-h5n1-studies/ar-AA1ywPAC
Mangoceuticals executes exclusive distribution agreement with Propre
February 4, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-executes-exclusive-distribution-agreement-with-propre-1034303717
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
February 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/03/3019515/0/en/mangoceuticals-inc-executes-exclusive-distribution-agreement-with-propre-energie-for-clinically-proven-dermytol-%ef%b8%8f-skincare-treatment-targeting-hyperpigmentation.html
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments
January 21, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-inc-finalizes-debt-conversion-and-appointments?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals
December 20, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-expands-with-patent-acquisition-in-nutraceuticals-1034159150
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
December 19, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/12/19/3000308/0/en/mangoceuticals-inc-completes-acquisition-of-mushroom-based-wellness-and-innovations-patent.html
Mangoceuticals, Inc. (MGRX) Latest Stock News & Headlines - Yahoo Finance
December 6, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/MGRX/news/
Mangoceuticals initiates investigation into potential stock manipulation
December 5, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-initiates-investigation-into-potential-stock-manipulation-1034097474
Mangoceuticals Signs Consulting Deal with CFO Johnston
November 14, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-signs-consulting-deal-with-cfo-johnston-1034003315
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
November 1, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-inc-regains-full-compliance-with-nasdaq-minimum-bid-price-requirement-1033927441
Mangoceuticals, Inc. (MGRX) Stock Price, News, Quote & History - Yahoo Finance
October 26, 2024  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/quote/MGRX/
Mangoceuticals board initiates process to evaluate strategic alternatives
October 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-board-initiates-process-to-evaluate-strategic-alternatives-1033871956
Mangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
October 22, 2024  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2024-10/63587151-mangoceuticals-inc-mangorx-responds-to-and-refutes-recent-claims-made-by-eli-lilly-399.htm
Mangoceuticals Defends Against Eli Lilly Allegations
October 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-defends-against-eli-lilly-allegations-1033866907
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit
October 22, 2024  |  seekingalpha.comhttps://seekingalpha.com/news/4187735-mangoceuticals-refutes-claims-made-by-lilly-in-weight-loss-drug-lawsuit
MangoRx Announces Formation of Strategy and Alternatives Committee
October 22, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/mangorx-announces-formation-strategy-alternatives-120000020.html
Mangoceuticals Opts For Strategic Alternatives
October 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-opts-for-strategic-alternatives-1033870422
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
October 21, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/10/21/2966542/0/en/mangorx-responds-to-and-refutes-recent-claims-made-by-eli-lilly.html
Stock Splits Do Matter and Here's What's Coming Next
October 16, 2024  |  247wallst.comhttps://247wallst.com/investing/2024/10/16/stock-splits-do-matter-and-heres-whats-coming-next/
Mangoceuticals announces 1-for-15 reverse stock split
October 13, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/mangoceuticals-announces-1-15-reverse-212008421.html
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
October 11, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/mangoceuticals-inc-announces-1-15-211500419.html
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
October 11, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/10/11/2962215/0/en/mangoceuticals-inc-announces-1-for-15-reverse-stock-split-as-part-of-nasdaq-compliance-plan.html
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
October 3, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/10/03/2957701/0/en/mangorx-introduces-oral-tirzepatide-glp-1-receptor-agonist-for-advanced-weight-loss-solutions.html
Shares of Healthcare Company Rise Following Product Availability Announcement
October 1, 2024  |  msn.comhttps://www.msn.com/en-us/money/markets/shares-of-healthcare-company-rise-following-product-availability-announcement/ar-AA1rxxT9
Healthcare Shares Rise Following Product Availability Announcement
October 1, 2024  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/commodities/ESM23/pressreleases/28825653/healthcare-shares-rise-following-product-availability-announcement/
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
October 1, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/mangorx-addresses-49-3-billion-113000298.html
Get Mangoceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.

MGRX Media Mentions By Week

MGRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MGRX
News Sentiment
▼
0.00

0.57
▲
Average
Medical
News Sentiment

MGRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MGRX Articles
This Week
▼
0

1
▲
MGRX Articles
Average Week

Get Mangoceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:MGRX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored